Top Markets
#1 Black Phoenix Black Phoenix +827.77%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +27.70%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.17%
#4 Bless Bless +22.57%
#5 pipedog pipedog +22.16%
#6 SAFEcoin SAFEcoin +20.09%
#7 Beam Beam +19.57%
#8 Magma Finance Magma Finance +19.26%
#9 PondCoin PondCoin +18.66%
#10 YFSX YFSX +15.99%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
PT Kalbe Farma Tbk. PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.

KLBF
Classifica tra le azioni #6215
PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its... PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. The company's diverse portfolio encompasses generic, branded, and licensed medications, including well-known names like Brainact, Cefspan, and Mycoral, which are supplied to hospitals, pharmacies, and various drugstores. Beyond prescription drugs, it offers non-prescription medicines, a range of energy and ready-to-drink beverages, dietary supplements, and other preventive health solutions. Kalbe Farma also produces specialized nutritional products tailored for all demographics, from infants to seniors, including expectant mothers and individuals with specific medical dietary needs. The firm extends contract services to other pharmaceutical companies, covering clinical study management, bioavailability/bioequivalence assessments, and analytical testing. Additionally, it provides animal health products and operates its own healthcare facilities, the Mitrasana Clinics. Its broad scope of activities further includes health screening, acting as an agent for biotechnology products, and the distribution of consumer items, medical devices, and cosmetics. The company also trades in medical and laboratory equipment and supplies, raw materials for pharmaceuticals, and consumables for hemodialysis therapy, in addition to offering advertising services. Founded in 1966, PT Kalbe Farma Tbk. is headquartered in Jakarta, Indonesia.
Prezzo delle azioni
$0.04784262
Capitalizzazione di mercato
$2.16B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-39.38%
Paese
ID
Scambia PT Kalbe Farma Tbk. (KLBF)

Categoria

Healthcare
Margine operativo per PT Kalbe Farma Tbk. (KLBF)
Margine operativo al 2026 TTM: 0.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PT Kalbe Farma Tbk., il margine operativo attuale (TTM) è 0.00%. Alla fine del 2026, il margine operativo era 0.00%.
Storico del margine operativo per PT Kalbe Farma Tbk. da 2026 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
Non abbastanza dati per le date fornite.
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
43.92% -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
26.81% -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
29.32% -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
26.59% -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
16.65% -
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.